So when the Cannabis Act was first passed in 2015, there were numerous concerns that made it such a controversial topic and a lot of these concerns stem from the fact that the ACT is going to be implemented on a municipal and provincial level instead of on National level. So these concerns were valid because different branches with the government May encounter.
He's when it comes to communication and standardizing the micro level decisions that they make as a result of the ACT even. So the Cannabis Act is a national level act. It is not address every single smaller decisions that stem from that bigger act and as a result, there may be discrepancies between the way that these
current branches are addressing issues that arise so some of the concerns that come to mind are concerns of accessibility concerns of safety and concerns of misinformation. So when it comes to accessibility, especially for products such as cannabis the our populations who rely heavily on the consumption of cannabis to ensure daily functioning to reduce chronic pain and
And making sure that the product is going to be accessible to them. No matter changes in health policies should be a priority and with the legalization and decriminalization of cannabis certain new new sellers May emerge in the market and take up that sort of space and mash
the demand that is constantly growing and
even though this is expected this needs to be addressed in a way that is consistent between different government branches and when it comes to safety, so if we talk about the second concern who are the stakeholders
And what are the limits that we are going to impose on the stakeholders? So there are numerous populations that
May be affected by decisions on a smaller basis. So for example, how how many licenses are we going to issue throughout the country who who will be permitted to be the manufacturer to grow cannabis, you know who who are going to be permitted to be Sellers and who will be responsible for assuring the quality.
tea and the safety of the product in our the same time we can think about the other side of the counter who are going to be the buyers whether it's the age limits what about cases that are less distinct cases that are more ambiguous, you know, and there's also the concern of conflicts of interest since medical cannabis is
To be covered by insurance only if it is prescribed by clinician as far as I know these clinics. There may be concerns of conflicts of interest because certain clinics Maybe
subjecting the patient to increase prescription however, consciously or subconsciously as a result of that interest and finally there's concern of misinformation and as with any controversial topic, there's always two ways risk of information misinformation when it comes to disseminating knowledge to the public who's going to have access to that information who is going to
be informed when they make certain decisions of whether to consume the product or not. And who's going to be going to be responsible in distributing that information making sure that they are accurate and responsible for generating new information on the topic. So the way that different government branches are handling this act is essential and